Study In Adults And Adolescents With Seasonal Allergic Rhinitis
Phase 3
Completed
- Conditions
- HayfeverRhinitis, Allergic, SeasonalSeasonal Allergic Rhinitis
- Registration Number
- NCT00115622
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as "hay fever", it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 304
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Mean change from baseline over the entire treatment period in daily, reflective, total nasal symptom scores. Mean change from baseline over the entire treatment period in the daily, reflective, total ocular symptom score.
- Secondary Outcome Measures
Name Time Method Mean change from baseline over the entire treatment period in AM, pre-dose, instantaneous, total nasal symptom score.
Trial Locations
- Locations (1)
GSK Investigational Site
🇺🇸San Antonio, Texas, United States